28125734|t|Identification of MiR-21-5p as a Functional Regulator of Mesothelin Expression Using MicroRNA Capture Affinity Coupled with Next Generation Sequencing
28125734|a|MicroRNAs (miRNAs) are small non-coding RNAs that regulate mRNA expression mainly by silencing target transcripts via binding to miRNA recognition elements (MREs) in the 3'untranslated region (3'UTR). The identification of bona fide targets is challenging for researchers working on the functional aspect of miRNAs. Recently, we developed a method (miR-CATCH) based on biotinylated DNA antisense oligonucleotides that capture the mRNA of interest and facilitates the characterisation of miRNAs::mRNA interactions in a physiological cellular context. Here, the miR-CATCH technique was applied to the mesothelin (MSLN) gene and coupled with next generation sequencing (NGS), to identify miRNAs that regulate MSLN mRNA and that may be responsible for its increased protein levels found in malignant pleural mesothelioma (MPM). Biotinylated MSLN oligos were employed to isolate miRNA::MSLN mRNA complexes from a normal cell line (Met-5A) which expresses low levels of MSLN. MiRNAs targeting the MSLN mRNA were identified by NGS and miR-21-5p and miR-100-5p were selected for further validation analyses. MiR-21-5p was shown to be able to modulate MSLN expression in miRNA mimic experiments in a panel of malignant and non-malignant cell lines. Further miRNA inhibitor experiments and luciferase assays in Mero-14 cells validated miR-21-5p as a true regulator of MSLN. Moreover, in vitro experiments showed that treatment with miR-21-5p mimic reduced proliferation of MPM cell lines. Altogether, this work shows that the miR-CATCH technique, coupled with NGS and in vitro validation, represents a reliable method to identify native miRNA::mRNA interactions. MiR-21-5p is suggested as novel regulator of MSLN with a possible functional role in cellular growth.
28125734	18	27	MiR-21-5p	T103	UMLS:C1101610
28125734	33	53	Functional Regulator	T017	UMLS:C0017362
28125734	57	67	Mesothelin	T017	UMLS:C1334533
28125734	68	78	Expression	T038	UMLS:C0017262
28125734	85	93	MicroRNA	T103	UMLS:C1101610
28125734	124	150	Next Generation Sequencing	T062	UMLS:C2936622
28125734	151	160	MicroRNAs	T103	UMLS:C1101610
28125734	162	168	miRNAs	T103	UMLS:C1101610
28125734	174	195	small non-coding RNAs	T103	UMLS:C0887909
28125734	201	209	regulate	T038	UMLS:C0017263
28125734	210	225	mRNA expression	T038	UMLS:C1515670
28125734	236	245	silencing	T038	UMLS:C0598496
28125734	253	264	transcripts	T103	UMLS:C1519595
28125734	269	276	binding	T038	UMLS:C1167622
28125734	280	313	miRNA recognition elements (MREs)	T082	UMLS:C0314659
28125734	321	342	3'untranslated region	T082	UMLS:C0600600
28125734	344	349	3'UTR	T082	UMLS:C0600600
28125734	374	383	bona fide	T082	UMLS:C2323869
28125734	411	430	researchers working	T033	UMLS:C0243095
28125734	459	465	miRNAs	T103	UMLS:C1101610
28125734	520	532	biotinylated	T038	UMLS:C1159274
28125734	533	536	DNA	T103	UMLS:C0012854
28125734	537	563	antisense oligonucleotides	T103	UMLS:C0079925
28125734	581	585	mRNA	T103	UMLS:C0035696
28125734	638	663	miRNAs::mRNA interactions	T038	UMLS:C1523523
28125734	669	691	physiological cellular	T038	UMLS:C1325880
28125734	750	772	mesothelin (MSLN) gene	T017	UMLS:C1334533
28125734	790	816	next generation sequencing	T062	UMLS:C2936622
28125734	818	821	NGS	T062	UMLS:C2936622
28125734	836	842	miRNAs	T103	UMLS:C1101610
28125734	848	856	regulate	T038	UMLS:C0017263
28125734	857	866	MSLN mRNA	T017	UMLS:C1334533
28125734	913	927	protein levels	T033	UMLS:C0428479
28125734	937	967	malignant pleural mesothelioma	T038	UMLS:C0812413
28125734	969	972	MPM	T038	UMLS:C0812413
28125734	975	987	Biotinylated	T038	UMLS:C1159274
28125734	988	999	MSLN oligos	T017	UMLS:C1334533
28125734	1025	1051	miRNA::MSLN mRNA complexes	T103	UMLS:C1099355
28125734	1066	1084	cell line (Met-5A)	T017	UMLS:C0007600
28125734	1091	1100	expresses	T038	UMLS:C1171362
28125734	1115	1119	MSLN	T103	UMLS:C0380162
28125734	1121	1127	MiRNAs	T103	UMLS:C1101610
28125734	1142	1151	MSLN mRNA	T017	UMLS:C1334533
28125734	1171	1174	NGS	T062	UMLS:C2936622
28125734	1179	1188	miR-21-5p	T103	UMLS:C1101610
28125734	1193	1203	miR-100-5p	T103	UMLS:C1101610
28125734	1230	1249	validation analyses	T062	UMLS:C0936012
28125734	1251	1260	MiR-21-5p	T103	UMLS:C1101610
28125734	1285	1293	modulate	T082	UMLS:C0443264
28125734	1294	1298	MSLN	T017	UMLS:C1334533
28125734	1299	1309	expression	T038	UMLS:C0017262
28125734	1313	1318	miRNA	T103	UMLS:C1101610
28125734	1319	1324	mimic	T058	UMLS:C0393040
28125734	1325	1336	experiments	T062	UMLS:C0681814
28125734	1351	1360	malignant	T017	UMLS:C0334227
28125734	1379	1389	cell lines	T017	UMLS:C0007600
28125734	1399	1404	miRNA	T103	UMLS:C1101610
28125734	1415	1426	experiments	T062	UMLS:C0681814
28125734	1431	1441	luciferase	T103	UMLS:C0024075
28125734	1442	1448	assays	T058	UMLS:C0005507
28125734	1452	1465	Mero-14 cells	T017	UMLS:C0007634
28125734	1476	1485	miR-21-5p	T103	UMLS:C1101610
28125734	1496	1505	regulator	T017	UMLS:C0017362
28125734	1509	1513	MSLN	T017	UMLS:C1334533
28125734	1558	1567	treatment	T058	UMLS:C0087111
28125734	1573	1582	miR-21-5p	T103	UMLS:C1101610
28125734	1583	1588	mimic	T058	UMLS:C0393040
28125734	1614	1617	MPM	T038	UMLS:C0812413
28125734	1618	1628	cell lines	T017	UMLS:C0007600
28125734	1701	1704	NGS	T062	UMLS:C2936622
28125734	1718	1728	validation	T062	UMLS:C1519941
28125734	1778	1802	miRNA::mRNA interactions	T038	UMLS:C1523523
28125734	1804	1813	MiR-21-5p	T103	UMLS:C1101610
28125734	1836	1845	regulator	T017	UMLS:C0017362
28125734	1849	1853	MSLN	T017	UMLS:C1334533
28125734	1889	1904	cellular growth	T038	UMLS:C0007595